Does early improvement predict response to the fast-dissociating D2 receptor antagonist JNJ-37822681 in patients with acute schizophrenia? ☆ ☆☆ Previous publications and presentations: The primary results from this study are submitted elsewhere. Data in the manuscript were previously presented as a poster at the 66th Annual Convention and Scientific Program of the Society of Biological Psychiatry (SOBP), held in San Francisco, CA, USA from 12 to 14 May 2011; the 51st Annual Scientific Meeting New Clinical Drug Evaluation Unit (NCDEU), held in Boca Raton, FL, USA from 13 to 16 June 2011; and the 24th European College of Neuropsychopharmacology (ECNP) Congress, held in Paris, France, from 3 to 7 September 2011. ☆
Titel:
Does early improvement predict response to the fast-dissociating D2 receptor antagonist JNJ-37822681 in patients with acute schizophrenia? ☆ ☆☆ Previous publications and presentations: The primary results from this study are submitted elsewhere. Data in the manuscript were previously presented as a poster at the 66th Annual Convention and Scientific Program of the Society of Biological Psychiatry (SOBP), held in San Francisco, CA, USA from 12 to 14 May 2011; the 51st Annual Scientific Meeting New Clinical Drug Evaluation Unit (NCDEU), held in Boca Raton, FL, USA from 13 to 16 June 2011; and the 24th European College of Neuropsychopharmacology (ECNP) Congress, held in Paris, France, from 3 to 7 September 2011. ☆
Auteur:
Anghelescu, Ion-George Janssens, Luc Kent, Justine de Boer, Peter Tritsmans, Luc Daly, Ella J. van Nueten, Luc Schmidt, Mark E.